Oklahoma Medical Research Foundation, Genes and Human Disease, Oklahoma City, OK, United States.
Cell Circuits and Epigenomics Program, Broad Institute, Cambridge, MA, United States.
Front Immunol. 2020 Dec 8;11:567342. doi: 10.3389/fimmu.2020.567342. eCollection 2020.
Sarcoidosis is a systemic inflammatory disease characterized by infiltration of immune cells into granulomas. Previous gene expression studies using heterogeneous cell mixtures lack insight into cell-type-specific immune dysregulation. We performed the first single-cell RNA-sequencing study of sarcoidosis in peripheral immune cells in 48 patients and controls. Following unbiased clustering, differentially expressed genes were identified for 18 cell types and bioinformatically assessed for function and pathway enrichment. Our results reveal persistent activation of circulating classical monocytes with subsequent upregulation of trafficking molecules. Specifically, classical monocytes upregulated distinct markers of activation including adhesion molecules, pattern recognition receptors, and chemokine receptors, as well as enrichment of immunoregulatory pathways HMGB1, mTOR, and ephrin receptor signaling. Predictive modeling implicated TGFβ and mTOR signaling as drivers of persistent monocyte activation. Additionally, sarcoidosis T cell subsets displayed patterns of dysregulation. CD4 naïve T cells were enriched for markers of apoptosis and Th17/T differentiation, while effector T cells showed enrichment of anergy-related pathways. Differentially expressed genes in regulatory T cells suggested dysfunctional p53, cell death, and TNFR2 signaling. Using more sensitive technology and more precise units of measure, we identify cell-type specific, novel inflammatory and regulatory pathways. Based on our findings, we suggest a novel model involving four convergent arms of dysregulation: persistent hyperactivation of innate and adaptive immunity classical monocytes and CD4 naïve T cells, regulatory T cell dysfunction, and effector T cell anergy. We further our understanding of the immunopathology of sarcoidosis and point to novel therapeutic targets.
结节病是一种全身性炎症性疾病,其特征是免疫细胞浸润到肉芽肿中。以前使用异质细胞混合物进行的基因表达研究缺乏对细胞类型特异性免疫失调的深入了解。我们对 48 名患者和对照者的外周免疫细胞中的结节病进行了首次单细胞 RNA 测序研究。在进行无偏聚类后,鉴定了 18 种细胞类型的差异表达基因,并进行了功能和途径富集的生物信息学评估。我们的研究结果揭示了循环经典单核细胞的持续激活,随后上调了趋化因子受体和免疫调节途径 HMGB1、mTOR 和 Ephrin 受体信号。预测模型表明 TGFβ和 mTOR 信号通路是持续激活单核细胞的驱动因素。此外,结节病 T 细胞亚群显示出失调模式。CD4 幼稚 T 细胞富集了凋亡和 Th17/T 分化的标志物,而效应 T 细胞则富集了无反应性相关途径。调节性 T 细胞中差异表达的基因提示 p53、细胞死亡和 TNFR2 信号通路功能障碍。使用更敏感的技术和更精确的测量单位,我们确定了特定于细胞类型的新型炎症和调节途径。基于我们的发现,我们提出了一个新的模型,涉及四个失调的收敛臂:固有和适应性免疫的持续过度激活(经典单核细胞和 CD4 幼稚 T 细胞)、调节性 T 细胞功能障碍和效应 T 细胞无反应性。我们进一步了解了结节病的免疫病理学,并指出了新的治疗靶点。